These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 7923826)

  • 1. Hyperinsulinaemia and Na+, K(+)-ATPase activity in thyrotoxic periodic paralysis.
    Chan A; Shinde R; Chow CC; Cockram CS; Swaminathan R
    Clin Endocrinol (Oxf); 1994 Aug; 41(2):213-6. PubMed ID: 7923826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo and in vitro sodium pump activity in subjects with thyrotoxic periodic paralysis.
    Chan A; Shinde R; Chow CC; Cockram CS; Swaminathan R
    BMJ; 1991 Nov; 303(6810):1096-9. PubMed ID: 1660744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin resistance in subjects with a history of thyrotoxic periodic paralysis (TPP).
    Soonthornpun S; Setasuban W; Thamprasit A
    Clin Endocrinol (Oxf); 2009 May; 70(5):794-7. PubMed ID: 18759868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical review: Thyrotoxic periodic paralysis: a diagnostic challenge.
    Kung AW
    J Clin Endocrinol Metab; 2006 Jul; 91(7):2490-5. PubMed ID: 16608889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Recent progress on the searchs of pathogenesis of thyrotoxic periodic paralysis].
    Shishiba Y
    Nihon Rinsho; 2006 Dec; 64(12):2339-47. PubMed ID: 17154102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperinsulinaemia in thyrotoxic hypokalaemic periodic paralysis.
    Lee KO; Taylor EA; Oh VM; Cheah JS; Aw SE
    Lancet; 1991 May; 337(8749):1063-4. PubMed ID: 1673496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thyrotoxic periodic paralysis and polymorphisms of sodium-potassium ATPase genes.
    Kung AW; Lau KS; Cheung WM; Chan V
    Clin Endocrinol (Oxf); 2006 Feb; 64(2):158-61. PubMed ID: 16430714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Thyrotoxic periodic paralysis. Discussion of the role of Na-K-ATPase, apropos of a case].
    Marlier S; Raccah D; Disdier P; Molle L; Harle JR; Vialettes B; Weiller PJ
    Rev Med Interne; 1995; 16(3):209-11. PubMed ID: 7740232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythrocyte sodium-potassium pump in thyrotoxic periodic paralysis.
    Lam KS; Yeung RT; Benson EA; Wang C
    Aust N Z J Med; 1989 Feb; 19(1):6-10. PubMed ID: 2548465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thyrotoxic periodic paralysis in a Hispanic man after the administration of prednisone.
    Liu Z; Braverman LE; Malabanan A
    Endocr Pract; 2006; 12(4):427-31. PubMed ID: 16901800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A 10-year analysis of thyrotoxic periodic paralysis in 135 patients: focus on symptomatology and precipitants.
    Chang CC; Cheng CJ; Sung CC; Chiueh TS; Lee CH; Chau T; Lin SH
    Eur J Endocrinol; 2013 Nov; 169(5):529-36. PubMed ID: 23939916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early diagnosis of thyrotoxic periodic paralysis: spot urine calcium to phosphate ratio.
    Lin SH; Chu P; Cheng CJ; Chu SJ; Hung YJ; Lin YF
    Crit Care Med; 2006 Dec; 34(12):2984-9. PubMed ID: 16971853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of sex steroid hormones, thyroid hormone levels, and insulin regulation on thyrotoxic periodic paralysis in Chinese men.
    Li W; Changsheng C; Jiangfang F; Bin G; Nanyan Z; Xiaomiao L; Deqiang L; Ying X; Wensong Z; Qiuhe J
    Endocrine; 2010 Dec; 38(3):386-90. PubMed ID: 20972724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The insulin-sensitivity sulphonylurea receptor variant is associated with thyrotoxic paralysis.
    Rolim AL; Lindsey SC; Kunii IS; Crispim F; Moisés RC; Maciel RM; Dias-da-Silva MR
    J Mol Endocrinol; 2014 Oct; 53(2):295-301. PubMed ID: 25143473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of novel single nucleotide polymorphisms in the calcium channel alpha 1 subunit gene (Ca(v)1.1) and thyrotoxic periodic paralysis.
    Kung AW; Lau KS; Fong GC; Chan V
    J Clin Endocrinol Metab; 2004 Mar; 89(3):1340-5. PubMed ID: 15001631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electrocardiographic manifestations in patients with thyrotoxic periodic paralysis.
    Hsu YJ; Lin YF; Chau T; Liou JT; Kuo SW; Lin SH
    Am J Med Sci; 2003 Sep; 326(3):128-32. PubMed ID: 14501227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transient glucose intolerance during attacks of thyrotoxic periodic paralysis.
    Hamada N; Ishii T; Hasegawa M; Ishikawa N; Tabata T; Okuno Y; Ito K; Matsuura S; Morii H; Wada M
    Horm Metab Res; 1985 Jun; 17(6):301-5. PubMed ID: 3894193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. INa and IKir are reduced in Type 1 hypokalemic and thyrotoxic periodic paralysis.
    Puwanant A; Ruff RL
    Muscle Nerve; 2010 Sep; 42(3):315-27. PubMed ID: 20589886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyrotoxic periodic paralysis in a Caucasian man in treatment for Graves' disease.
    Didonna D; D'Alessandro G; De Michele A; Conte M; Storelli A; Totaro M; Altomare E
    Panminerva Med; 2000 Dec; 42(4):293-4. PubMed ID: 11294094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analytic review: thyrotoxic periodic paralysis: a review.
    Pothiwala P; Levine SN
    J Intensive Care Med; 2010; 25(2):71-7. PubMed ID: 20089526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.